World's first generic to leading GnRH analogue with controlled release
Xbrane is pioneering high demand biosimilars.
OUTPERFORMING INDUSTRY STANDARDS BY DEVELOPING BIOSIMILARS WITH NEXT GENERATION TECHNOLOGY
Enabling access to critical medication for life critical diseases
Investors
Latest News
-
Xbrane bjuder in till ett webbseminarium om det nyligen ingångna samarbetsavtalet med STADA
Read more >> -
Xbrane invites to a webinar about the recently entered co-development agreement with STADA
Read more >> -
Xbrane och STADA ingår samarbetsavtal för Xlucane
Read more >> -
Xbrane and STADA enter into a co-development agreement for Xlucane
Read more >> -
Xbrane Biopharma informs about GDPR and how we handle your personal information
Read more >>
X
